These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38870352)

  • 1. Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.
    Sardar S; Jyotisha ; Amin SA; Khatun S; Qureshi IA; Patil UK; Jha T; Gayen S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5642-5656. PubMed ID: 38870352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.
    Sixto-López Y; Bello M; Correa-Basurto J
    J Biomol Struct Dyn; 2019 Feb; 37(3):584-610. PubMed ID: 29447615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
    Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
    Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired
    Zhang H; Shen Q; Hu Z; Wu PQ; Chen Y; Zhao JX; Yue JM
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Phytocompounds for Identification of Prospective Histone Deacetylase 1 (HDAC1) Inhibitor: An In Silico Molecular Docking, Molecular Dynamics Simulation, and MM-GBSA Approach.
    Bharadwaj KK; Ahmad I; Pati S; Ghosh A; Rabha B; Sarkar T; Bhattacharjya D; Patel H; Baishya D
    Appl Biochem Biotechnol; 2024 Jul; 196(7):3747-3764. PubMed ID: 37776441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches.
    Zhu Y; Li HF; Lu S; Zheng YX; Wu Z; Tang WF; Zhou X; Lu T
    Eur J Med Chem; 2010 May; 45(5):1777-91. PubMed ID: 20153566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering the binding modes of natural products with histone deacetylase 1.
    Zhang L; Li M; Zhang L; Xu W
    Med Chem; 2013 Feb; 9(1):126-32. PubMed ID: 22779791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches.
    Bhattacharya A; Amin SA; Kumar P; Jha T; Gayen S
    J Mol Graph Model; 2023 Sep; 123():108510. PubMed ID: 37216830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone.
    Lin Y; Zhang H; Niu T; Tang ML; Chang J
    Molecules; 2020 Sep; 25(19):. PubMed ID: 33007982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
    Singh R; Pandey PN
    Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
    Kashyap K; Kakkar R
    J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
    Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity.
    Lecointre B; Narozny R; Borrello MT; Senger J; Chakrabarti A; Jung M; Marek M; Romier C; Melesina J; Sippl W; Bischoff L; Ganesan A
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.
    Yuan Y; Hu Z; Bao M; Sun R; Long X; Long L; Li J; Wu C; Bao J
    J Biomol Struct Dyn; 2019 Sep; 37(15):4092-4103. PubMed ID: 30417746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.
    Gao S; Zang J; Gao Q; Liang X; Ding Q; Li X; Xu W; Chou CJ; Zhang Y
    Bioorg Med Chem; 2017 Jun; 25(12):2981-2994. PubMed ID: 28511906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
    Ortore G; Di Colo F; Martinelli A
    J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.